Clinical TrialsSearch results
Number of results: 416
Other
- Phase II trial of cetuximab plus irinotecan for FOLFOX and FOLFIRI-refractory patients with EGFR-positive advanced and/or metastatic colorectal cancer, evaluation of the safety and efficacy based on KRAS mutation status (T-CORE0801)
- 3rd line or later therapy for unresectable advanced and/or recurrent colorectal cancer
- NPO T-CORE (Tohoku Clinical Oncology Research and Education Society)
- 2009-01-31
Other
- Phase II trial neoadjuvant chemoradiation therapy with gemcitabine and surgical resection for advanced cholangiocarcinoma patients
- cholangiocarecinoma:Stage III and IV of the Japanese General Rules for Surgical and Pathological Studies on Cancer of the Biliary Tract
- Hepato-biliary pancreatic surgery,Tohoku University Hospital
- 2009-03-04
Other
- Phase II Study of Thymomectomy for Thymoma Localized in the Thymus
- thymoma
- Japanese Association for Research on the Thymus
- 2007-04-01
Recruiting
- Phase II study of the safety and efficacy of TM5614 in combination with Paclitaxel for cutaneous angiosarcoma
- Cutaneous Hemangiosarcoma
- Fujimura Taku
- 2023-07-15
Other
- Phase II study of Rituximab in Patients with Systemic Lupus Erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-07-05
Completed
- Phase II study of ramucirumab plus paclitaxel therapy for elderly patients with non-resectable or metastatic gastric cancer (T-CORE1501)
- gastric cancer
- Ishioka Chikashi
- 2019-03-25
Other
- Phase II study of Neoadjuvant chemotherapy with Gemcitabine and S1 (GS therapy) for resectable pancreatic carcinoma
- resectable pancreatic cancer
- Department of surgery, Tohoku University
- 2008-11-13
Other
- Phase II study of micafungin as empirical antifungal therapy for febrile neutropenic patients (C-SHOT 0503 study)
- Febrile neutropenia
- Center for Supporting Hematology-Oncology Trials (C-SHOT)
- 2006-03-30
Other
- Phase II study of irinotecan and tegafur gimeracil for NSCLC with EGFR mutation which resistant to EGFR-TKI
- Non-small-cell lung cancer
- North Japan Lung Cancer Study Group
- 2010-08-31
Other
- Phase II study of imatinib mesylate for treatment of Philadelphia Chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in children: A Japanese Cooperative Trial
- Philadelphia Chromosome-positive acute lymphoblastic leukemia
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)
- 2005-12-01